-
Trilaurin Workflows for Biocatalysis and Drug Delivery
2026-09-10
Trilaurin connects renewable-feedstock biocatalysis with lipid-based delivery systems, from laurylamine synthesis to oral protection of peptide and protein payloads. This practical guide covers assay setup, formulation choices, scale-up benchmarks, and troubleshooting for more reproducible bench workflows.
-
Rotigotine Hydrochloride in Translational PD
2026-09-10
Rotigotine hydrochloride is more than a conventional dopaminergic tool. Its D2/D3 agonism, broader receptor activity, transdermal clinical history, and analytical liabilities create a strategic framework for designing more reproducible Parkinson’s disease research and translational studies.
-
ECE-1c Stability, CK2, and Cisplatin Resistance
2026-09-09
The 2024 study identifies a non-canonical mechanism in which the K6R variant of ECE-1c promotes stemness, cisplatin resistance, and invasion in non-small cell lung cancer cells without increasing short-term ET-1 secretion. Its findings connect CK2-dependent ECE-1c regulation with cancer aggressiveness and support Silmitasertib as a mechanistic tool for testing this pathway, while highlighting the need for in vivo and clinical validation.
-
Galectin-1–FIP200 Axis in Hepatic Steatosis
2026-09-09
A 2026 study identifies galectin-1 as a causal inhibitor of hepatic autophagy, linking its interaction with FIP200 to steatosis, dyslipidemia, and insulin resistance. By integrating mouse models, proteomics, binding analysis, structural mapping, and interaction-disrupting mutations, the work defines a mechanistic target for metabolic liver disease research.
-
Lysosomal β-Galactosidase Staining Kit in HNSCC
2026-09-08
The Lysosomal β-Galactosidase Staining Kit provides a spatial lysosomal control for interpreting cellular senescence in HNSCC cisplatin-resistance models. This guide connects the K2181 assay to SLC25A1 biology while defining what its blue X-gal signal can—and cannot—prove.
-
α-KG, LKB1-AMPK, and Periodontal Stem-Cell Senescence
2026-09-08
The reference study identifies an α-ketoglutarate–LKB1-AMPK axis that restores mitochondrial homeostasis and limits inflammation-induced senescence in human periodontal ligament stem cells. Its combination of mitochondrial, senescence, osteogenic, pharmacological, and animal-model evidence provides a mechanistic framework for studying periodontal regeneration under inflammatory stress.
-
MPC, Lactate, and Histone Lactylation in CRC
2026-09-07
The 2025 reference study identifies a metabolic–epigenetic–immune pathway in colorectal cancer: reduced MPC1/MPC2 activity increases lactate, elevates histone lactylation in dendritic cells, and weakens CD8+ T-cell responses. Its experiments connect mitochondrial pyruvate handling with dendritic-cell maturation and anti-PD-1 efficacy, while also defining important limits for translating the findings to other lactate-centered research systems.
-
Thymosin-β4 and Notch/NF-κB in Limb Ischemia
2026-09-05
A 2020 study linked thymosin-β4 overexpression with improved endothelial angiogenic behavior and activation of the Notch/NF-κB axis in critical limb ischemia models. Its combined cell, animal, inhibitor, and molecular readouts provide a useful framework for studying pathway-dependent neovascularization while highlighting the limits of overexpression and pharmacological evidence.
-
DAPI Solution (1 mg/mL): Reliable Apoptosis Staining
2026-09-05
Learn how DAPI Solution (1 mg/mL), SKU K2401, supports reproducible nuclear visualization, viability assessment, and apoptosis-oriented workflows in microscopy and flow cytometry. This scenario-based guide covers assay design, controls, interpretation, protocol parameters, and practical vendor-selection criteria.
-
Recombinant Human Oncostatin M in Fibroblast Assays
2026-09-04
Recombinant Human Oncostatin M provides a defined cytokine perturbation for studying fibroblast proliferation, inflammatory signaling, and senescence-associated phenotypes. This article connects rh-Oncostatin M assay design with mitochondrial-quality measurements from a 2025 dermal fibroblast study, while clearly separating established evidence from new experimental hypotheses.
-
Octenidine Dihydrochloride Research Workflows
2026-09-04
Build reproducible membrane-disruption, planktonic, and biofilm assays around Octenidine dihydrochloride while controlling solubility, adsorption, and endpoint bias. The compound is also a practical benchmark for evaluating next-generation gemini quaternary ammonium compounds, provided that derivative performance is not assumed to transfer automatically.
-
MK0787 Versus New β-Lactams: 1982 Evidence
2026-09-03
Cullmann and colleagues evaluated N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and compared it directly with several emerging β-lactam antibiotics, including Cefoperazone. The study’s main contribution was to connect organism-specific MIC patterns, bactericidal activity, and β-lactamase independence in a standardized in vitro framework that remains useful for interpreting comparative antimicrobial data.
-
EV-Transferred ACLY Drives TAM Differentiation in HCC
2026-09-03
The reference study identifies extracellular vesicle transfer of ATP-citrate lyase as a metabolic mechanism that converts monocytes into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered CD81-decorated liposomal system provides a targeted strategy for blocking this axis and improving anti-PD-1/PD-L1 activity.
-
Stiripentol LDH Inhibitor: Research Workflows
2026-09-02
Stiripentol is a chemically distinct LDH inhibitor for controlled studies of lactate flux, astrocyte-neuron lactate shuttle modulation, and seizure biology. Its pharmacological action also provides a hypothesis-generating tool for testing how lactate metabolism and histone lactylation influence dendritic-cell and CD8+ T-cell function in colorectal cancer models.
-
BI 2536 for Reliable PLK1 Cell Assays
2026-09-02
BI 2536 (SKU A3965) offers a potent, selective PLK1 perturbation tool for interpreting proliferation, cell-cycle arrest, and apoptosis in cancer research. This scenario-based guide connects formulation, assay design, data interpretation, and vendor selection to improve the clarity and comparability of cell-based experiments.